Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens
Sawant, N; Kaur, K; Holland, DA; Hickey, JM; Agarwal, S; Brady, JR; Dalvie, NC; … Volkin, DB; + view all Sawant, N; Kaur, K; Holland,...